Research and Markets Ltd

Fundamentals of Antiparasitic and Antibacterial Drug Discovery From Molecular Targets to Drug Candidates

Published in Drug Law Weekly, April 21st, 2009

Research and Markets has announced the addition of John Wiley and Sons Ltd's new report "Antiparasitic and Antibacterial Drug Discovery: From Molecular Targets to Drug Candidates" to their offering.

Addressing parasitic diseases and diseases caused by bacteria, this much-needed reference and handbook provides a unique insight into the approach adopted by academic and commercial science towards infectious diseases, including the work of medicinal chemists.

Many of the authors are scientists with hands-on experience of drug discovery units within the pharmaceutical industry. In...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Law Weekly

Source: Drug Law Weekly (2009-04-21)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry